Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Respiratory Research|June 21, 2017
Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD)Sean Duffy, Robert Marron, Helen Voelker, et al.
JCI Insight|November 16, 2018
Elevated circulating MMP-9 is linked to increased COPD exacerbation risk in SPIROMICS and COPDGeneJ Michael Wells, Margaret M Parker, Robert A Oster, et al.
American Journal of Respiratory and Critical Care Medicine|October 23, 2024
Serum Immunoglobulin G Levels Are Associated with Risk for Exacerbations: An Analysis of SPIROMICSMichael Burnim, Nirupama Putcha, David LaFon, et al.
The Lancet. Respiratory Medicine|July 3, 2017
Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohortMeiLan K Han, Pedro M Quibrera, Elizabeth E Carretta, et al.
American Journal of Respiratory and Critical Care Medicine|May 10, 2022
Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage Chronic Obstructive Pulmonary DiseaseSiddharth S Madapoosi, Charmion Cruickshank-Quinn, Kristopher Opron, et al.
Annals of the American Thoracic Society|March 11, 2025
Longitudinal Outcomes in Pi*MZ Alpha-1 Antitrypsin Deficient Individuals with Tobacco Smoking History from the SPIROMICS CohortIgor Barjaktarevic, Roxana Hixson, Zian Zhuang, et al.
ERJ Open Research|November 5, 2025
Extracellular iron and the lung microbiome in smoking and COPDClaire Healy, Christina Campbell, Katherine Hoffman, et al.
Pageof 4